Ping Shan

Biotechnology Research Center, Cuixi Academy of Biotechnology, Zhuji, 311800, China
Author    Correspondence author
GMO Biosafety Research, 2024, Vol. 15, No. 3   
Received: 14 May, 2024    Accepted: 17 Jun., 2024    Published: 26 Jun., 2024

This is an open access article published under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

The advent of precision genome engineering has revolutionized the field of biotechnology, offering unprecedented accuracy in modifying DNA sequences. This study explores the future of genome engineering, focusing on the precision, efficiency, and ethical considerations associated with these technologies. Precision genome engineering, facilitated by tools such as CRISPR-Cas9, TALENs, and ZFNs, allows for targeted modifications in the genome, enabling advancements in both medical and agricultural applications. CRISPR-Cas9, in particular, has emerged as a game-changer, offering the potential to treat genetic disorders and enhance crop resilience. However, the power to edit the human genome raises significant ethical concerns, necessitating a framework for responsible use. The study highlights the importance of ongoing discussions among scientists, policymakers, and the public to navigate the ethical landscape and ensure the safe and beneficial application of genome engineering technologies. As we stand on the brink of a new era in genomics, the potential for transformative impacts on healthcare, agriculture, and our understanding of genetic information is immense, but must be approached with caution and ethical foresight.

Precision genome engineering; CRISPR-Cas9; Ethical considerations; Genetic disorders; Agricultural biotechnology